Immune
Longevity
Clinical
Compounded / restricted

Thymosin Alpha-1

Also known as Tα1 · Thymalfasin · Zadaxin

New

Reconstitution & dosing guide

5 mg · 10 mg vial sizes — research phases, recon steps, and a live unit calculator.

Open guide

Available sizes & price

Catalog only

10mg x 10 vials

Thymosin alpha 1 (TA10) · Not in current stock

$70 / vial

Add

5mg x 10 vials

Thymosin alpha 1 (TA5) · Not in current stock

$45 / vial

Add

Prices per vial · Research use only · Not medical advice.

Immune-modulating peptide used clinically in some countries for hepatitis and as an immune adjuvant.

How to picture it

Thymosin Alpha-1 is a thymic peptide that modulates how innate sensors (TLRs) and T-cells work together — smarter immune surveillance rather than simply turning inflammation to maximum. Picture an immune-education coach: coordinating how the system notices threats and trains T-cell responses, with substantial human research in infection, vaccine response, and immune-oncology adjunct settings.

Research focus & benefits

  • Immune modulation and T-cell research
  • Infection and vaccine-response literature
  • Immune-oncology adjunct studies
  • Relatively strong human evidence among research peptides

Benefits describe research interest and pathway rationale — not guaranteed outcomes or medical advice. Research use only.

Overview

Thymosin alpha-1 is a 28-amino-acid peptide that enhances T-cell function and innate immune signaling. It has regulatory approvals in various countries (e.g., as thymalfasin/Zadaxin) for certain viral and immune indications, and is discussed in longevity medicine for immune senescence.

Mechanism

Promotes T-cell differentiation/maturation and modulates inflammatory cytokine patterns; used as an immune response enhancer.

Research uses

  • Chronic hepatitis B/C (regional approvals)
  • Vaccine adjuvant research
  • Sepsis and immune dysfunction studies
  • Cancer immunotherapy adjunct research

Research dosing notes

Clinical schedules vary by indication and region. Longevity clinic dosing is off-label where used.

Open full reconstitution & dosing guide →

Half-life / kinetics

Short; multi-weekly injection schedules in clinical use

Common research routes

Subcutaneous injection

Reported considerations

  • Injection-site discomfort
  • Flu-like symptoms (uncommon)
  • Generally favorable clinical tolerability where studied

Contraindications / cautions

  • Hypersensitivity
  • Autoimmune disease caution (immunomodulation)
  • Pregnancy caution

Common research stacks

  • Epithalon (longevity clinic stacks)
  • Vitamin D / lifestyle immune basics

Legal / access note

Approved in multiple countries for specific indications; US availability and compounding rules have fluctuated. Not a casual OTC immune booster.